Rich Small

Rich Small joined Neurotech in 2007 and has been Neurotech’s CEO since December 2017. Rich previously served as the Company’s COO and CFO. He has over 25 years of private and public life science experience and over 35 years of financial and operational management experience. Prior to Neurotech, Rich served as the CFO of Point Therapeutics and Immulogic Pharmaceuticals, both publicly-traded biotechnology company’s. Rich has been involved in completing several public and private financings, corporate partnerships and mergers. Rich is also an Executive Committee Board member at the New England College of Optometry. His early career was spent in senior management positions at Dennison Mfg. and the public accounting firm of PwC. Rich is a CPA and has a BS in accounting from Northeastern University.